📣 VC round data is live. Check it out!

Tsuruha Holdings Valuation Multiples

Discover revenue and EBITDA valuation multiples for Tsuruha Holdings and similar public comparables like MatsukiyoCocokara, CR Pharmaceutical, Droga Raia, Yifeng Pharmacy and more.

Tsuruha Holdings Overview

About Tsuruha Holdings

Tsuruha Holdings Inc manages pharmaceutical companies in Japan, where the drugstore business is the core of their operations. The company generates revenue through selling prescription and over-the-counter drugs, medical supplies, nursing care products, discount cosmetics, health products, and a miscellaneous assortment of general merchandise. It also provides blood testing services, disease prevention solutions, and at-home drug delivery services.


Founded

1929

HQ

Japan

Employees

32.6K

Sectors

Financials (LTM)

Revenue: $10B
EBITDA: $665M

EV

$6B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Tsuruha Holdings Financials

Tsuruha Holdings reported last 12-month revenue of $10B and EBITDA of $665M.

In the same LTM period, Tsuruha Holdings generated $3B in gross profit, $665M in EBITDA, and $274M in net income.

Revenue (LTM)


Tsuruha Holdings P&L

In the most recent fiscal year, Tsuruha Holdings reported revenue of $5B and EBITDA of $288M.

Tsuruha Holdings is profitable as of last fiscal year, with gross margin of 30%, EBITDA margin of 5%, and net margin of 2%.

See analyst estimates for Tsuruha Holdings
LTMLast FY202320242025202620272028
Revenue$10B$5B$6B$6B$8B
Gross Profit$3B$2B$2B$2B$3B
Gross Margin31%30%30%30%31%
EBITDA$665M$288M$390M$305M$536M
EBITDA Margin6%5%6%5%6%
EBIT Margin4%4%5%5%4%
Net Profit$274M$110M$155M$117M$242M
Net Margin3%2%2%2%3%

Financial data powered by Morningstar, Inc.

Tsuruha Holdings Stock Performance

Tsuruha Holdings has current market cap of $6B, and enterprise value of $6B.

Market Cap Evolution


Tsuruha Holdings' stock price is $13.18.

Tsuruha Holdings share price increased by 2.6% in the last 30 days, and decreased by 7.4% in the last year.

Tsuruha Holdings has an EPS (earnings per share) of $0.24.

See more trading valuation data for Tsuruha Holdings
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$6B$6B0.0%2.6%-20.3%-7.4%$0.24

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Tsuruha Holdings Valuation Multiples

Tsuruha Holdings trades at 0.6x EV/Revenue multiple, and 9.0x EV/EBITDA.

See NTM and 2027E valuation multiples for Tsuruha Holdings

EV / Revenue (LTM)


Tsuruha Holdings Financial Valuation Multiples

As of May 4, 2026, Tsuruha Holdings has market cap of $6B and EV of $6B.

Tsuruha Holdings has a P/E ratio of 21.8x.

LTMLast FY202320242025202620272028
EV/Revenue0.6x1.1x0.9x1.1x0.7x
EV/EBITDA9.0x20.8x15.4x19.7x11.2x
EV/EBIT13.9x24.9x19.4x23.7x16.2x
EV/Gross Profit1.9x3.7x3.1x3.5x2.3x
P/E21.8x54.5x38.6x51.1x24.7x
EV/FCF16.8x22.6x99.3x25.1x15.7x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Tsuruha Holdings Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Tsuruha Holdings Margins & Growth Rates

Tsuruha Holdings grew revenue by 69% and EBITDA by 103% in the last fiscal year.

In the most recent fiscal year, Tsuruha Holdings reported gross margin of 30%, EBITDA margin of 5%, and net margin of 2%.

See estimated margins and future growth rates for Tsuruha Holdings

Tsuruha Holdings Margins

Last FY202420252026202720282029
Gross Margin30%30%31%31%
EBITDA Margin5%5%6%6%
EBIT Margin4%5%4%4%
Net Margin2%2%3%2%
FCF Margin5%4%5%1%

Tsuruha Holdings Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth69%(14%)52%77%
Gross Profit Growth70%(14%)53%80%
EBITDA Growth103%(22%)76%78%
EBIT Growth64%(18%)46%54%
Net Profit Growth145%(24%)107%22%
FCF Growth53%296%60%(54%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Tsuruha Holdings Operational KPIs

Tsuruha Holdings' revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.0M for the same period.

Tsuruha Holdings' Rule of 40 is 84% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Tsuruha Holdings' Rule of X is 200% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Tsuruha Holdings
LTMLast FY202320242025202620272028
Rule of 4064%84%
Bessemer Rule of X150%200%
Revenue per Employee$0.2M
Opex per Employee$0.0M
Opex to Revenue26%26%26%16%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Tsuruha Holdings Competitors

Tsuruha Holdings competitors include MatsukiyoCocokara, CR Pharmaceutical, Droga Raia, Yifeng Pharmacy, Jointown Pharmaceutical, Clicks Group, Nahdi Medical, Sugi Holdings, DaShenLin Pharmaceutical and Alibaba Health.

Most Tsuruha Holdings public comparables operate across Pharmacies.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
MatsukiyoCocokara0.7x0.7x7.4x7.7x
CR Pharmaceutical0.3x0.3x4.1x4.3x
Droga Raia1.1x1.0x13.1x13.3x
Yifeng Pharmacy0.9x0.9x5.3x7.3x
Jointown Pharmaceutical0.2x0.2x5.3x5.7x
Clicks Group1.3x1.2x9.3x9.0x
Nahdi Medical1.4x1.4x8.5x8.4x
Sugi Holdings0.6x0.5x9.7x7.9x

This data is available for Pro users. Sign up to see all Tsuruha Holdings competitors and their valuation data.

Start Free Trial

Tsuruha Holdings Investment Activity

Tsuruha Holdings has invested in 1 company to date.

Latest investment by Tsuruha Holdings was on October 26th 2020. Tsuruha Holdings invested in RAINBOW in their $1M Seed round (EV/Revenue multiple of ).

See VC round multiples

Latest Investments by Tsuruha Holdings

RAINBOW
Description
RAINBOW is a Tokyo-based biopharmaceutical company developing HUNS001, an autologous mesenchymal stem cell therapy for stroke treatment. Administered via stereotactic injection to the peri-infarct zone, the product employs proprietary culture and delivery methods. Founded in 2018, RAINBOW conducts Phase II trials in Japan, emphasizing safety profiles from preclinical data showing neuroprotection and functional recovery in animal models.
HQ CountryJapan
HQ City
Tokyo
Deal Date26 Oct 2020
RoundSeed
Raised$1M
InvestorsD2 Garage Japan; Hokkaido Research Institute for the Twenty-first Century; Okasan Capital Partners; Tsuruha Holdings
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Tsuruha Holdings investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Tsuruha Holdings

When was Tsuruha Holdings founded?Tsuruha Holdings was founded in 1929.
Where is Tsuruha Holdings headquartered?Tsuruha Holdings is headquartered in Japan.
How many employees does Tsuruha Holdings have?As of today, Tsuruha Holdings has over 32K employees.
Who is the CEO of Tsuruha Holdings?Tsuruha Holdings' CEO is Jun Tsuruha.
Is Tsuruha Holdings publicly listed?Yes, Tsuruha Holdings is a public company listed on Tokyo Stock Exchange.
What is the stock symbol of Tsuruha Holdings?Tsuruha Holdings trades under 3391 ticker.
When did Tsuruha Holdings go public?Tsuruha Holdings went public in 2005.
Who are competitors of Tsuruha Holdings?Tsuruha Holdings main competitors include MatsukiyoCocokara, CR Pharmaceutical, Droga Raia, Yifeng Pharmacy, Jointown Pharmaceutical, Clicks Group, Nahdi Medical, Sugi Holdings, DaShenLin Pharmaceutical, Alibaba Health.
What is the current market cap of Tsuruha Holdings?Tsuruha Holdings' current market cap is $6B.
What is the current revenue of Tsuruha Holdings?Tsuruha Holdings' last 12 months revenue is $10B.
What is the current revenue growth of Tsuruha Holdings?Tsuruha Holdings revenue growth (NTM/LTM) is 57%.
What is the current EV/Revenue multiple of Tsuruha Holdings?Current revenue multiple of Tsuruha Holdings is 0.6x.
Is Tsuruha Holdings profitable?Yes, Tsuruha Holdings is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Tsuruha Holdings?Tsuruha Holdings' last 12 months EBITDA is $665M.
What is Tsuruha Holdings' EBITDA margin?Tsuruha Holdings' last 12 months EBITDA margin is 6%.
What is the current EV/EBITDA multiple of Tsuruha Holdings?Current EBITDA multiple of Tsuruha Holdings is 9.0x.
What is the current FCF of Tsuruha Holdings?Tsuruha Holdings' last 12 months FCF is $357M.
What is Tsuruha Holdings' FCF margin?Tsuruha Holdings' last 12 months FCF margin is 3%.
What is the current EV/FCF multiple of Tsuruha Holdings?Current FCF multiple of Tsuruha Holdings is 16.8x.
How many companies Tsuruha Holdings has acquired to date?Tsuruha Holdings hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Tsuruha Holdings has invested to date?As of May 2026, Tsuruha Holdings has invested in 1 company.
What was the last Tsuruha Holdings investment?On 26th October 2020 Tsuruha Holdings invested in RAINBOW, participating in a $1M Seed round, alongside D2 Garage Japan, Hokkaido Research Institute for the Twenty-first Century, and Okasan Capital Partners.
In what companies Tsuruha Holdings invested in?Tsuruha Holdings invested in RAINBOW.

See public comps similar to Tsuruha Holdings

Lists including Tsuruha Holdings

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial